Bio-Rad Laboratories (BIO) Income from Non-Controlling Interests (2009 - 2013)
Bio-Rad Laboratories' (BIO) quarterly Income from Non-Controlling Interests came in at $21000.0 in Q1 2013, up 134.43% year-on-year from $8958.0 in Q1 2012, and up 126.58% on a QoQ basis from -$79000.0 in Q4 2012.
Bio-Rad Laboratories (BIO) Income from Non-Controlling Interests (2009 - 2013) Analysis & Trends
Bio-Rad Laboratories (BIO) has 5 years of Income from Non-Controlling Interests data on file, last reported at $21000.0 in Q1 2013.
- On a quarterly basis, Income from Non-Controlling Interests rose 134.43% year-over-year to $21000.0 in Q1 2013; TTM through Dec 2013 was $21000.0, a 69.57% decrease from a year earlier, with the FY2013 full-year figure at $21000.0, down 69.57% from the prior year.
- Income from Non-Controlling Interests for Q1 2013 stood at $21000.0, up from -$79000.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for BIO reached as high as $776000.0 in Q3 2009 and fell as low as -$1.3 million in Q2 2009.
- Historically, Income from Non-Controlling Interests has averaged $90000.0 across 5 years, with a median of $4000.0 in 2012.
- Across the five-year window, Income from Non-Controlling Interests sank 231.03% in 2011 and soared 953.85% in 2012, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at $660000.0 in 2009, then slumped by 95.61% to $29000.0 in 2010, then sank by 231.03% to -$38000.0 in 2011, then sank by 107.89% to -$79000.0 in 2012, then jumped by 126.58% to $21000.0 in 2013.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $21000.0 in Q1 2013, -$79000.0 in Q4 2012, and -$13000.0 in Q3 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -5.85 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 21,000.00 |
| Dec 31, 2012 | -79,000.00 |
| Sep 30, 2012 | -13,000.00 |
| Jun 30, 2012 | 222,000.00 |
| Mar 31, 2012 | -61,000.00 |
| Dec 31, 2011 | -38,000.00 |
| Sep 30, 2011 | -35,000.00 |
| Jun 30, 2011 | -26,000.00 |
| Mar 31, 2011 | -101,000.00 |
| Dec 31, 2010 | 29,000.00 |
| Sep 30, 2010 | 321,000.00 |
| Jun 30, 2010 | 564,000.00 |
| Mar 31, 2010 | 531,000.00 |
| Dec 31, 2009 | 660,000.00 |
| Sep 30, 2009 | 776,000.00 |
| Jun 30, 2009 | -1.33 Mn |